|
Sunday, 08/01/2010
|
Borrowing from Survival Analysis to Assess Lumber Strength
Lang Wu, The University of British Columbia; Jim Zidek, The University of British Columbia; Lucy Cheng, The University of British Columbia; Sameoul Wong, Harvard University; Conroy Lum, Forintek Canada; Ciprian Pirvu, Forintek Canada
2:05 PM
|
Understanding the Spatial Dynamics of Comandra Bluster Rust in British Columbia Forests
Charmaine Dean, Simon Fraser University; Cindy Feng, Simon Fraser University; Richard Reich, Ministry of Forests and Range
2:35 PM
|
A Joint Model for Longitudinal Measurements and Competing Risks Survival Data
Gang Li, University of California, Los Angeles
3:05 PM
|
Challenges and Possible Solutions for Survival Analysis with High-Dimensional Covariates
Sihai Dave Zhao, Harvard University/Dana-Farber Cancer Institute; Yi Li, Harvard University/Dana-Farber Cancer Institute
4:05 PM
|
On the Clinical Meaningfulness of a Treatment's Effect on a Time-to-Event Variable
Qi Jiang, Amgen Inc.; Steven Snapinn, Amgen Inc.
4:05 PM
|
Generalized Forward Selection: Subset Selection in High Dimensions
Derick R. Peterson, University of Rochester; Alexander T. Pearson, University of Rochester
4:20 PM
|
Parametric and Nonparametric Survival Analysis of Cancer Data
Bong-Jin Choi, University of South Florida; Chris P. Tsokos, University of South Florida
4:20 PM
|
Recent Developments in Multivariate Survival Analysis
Lei Xu, University of Washington; Ross L. Prentice, Fred Hutchinson Cancer Research Center
4:30 PM
|
Determination of Optimal Cut Point for Competing Risks Data
Jeong Youn Lim, University of Pittsburgh; Jong-Hyeon Jeong, University of Pittsburgh
4:35 PM
|
Exploring Center Effects in Randomized Studies with Censored Endpoints
Richard McNally, Celgene Corporation; Sarah H. Kogut, Celgene Corporation
4:35 PM
|
Interval-Censored Time-to-Event Data in Clinical Trials: Analyzing and Designing
Xing Sun, Merck & Co., Inc.; Cong Chen, Merck & Co., Inc.
4:50 PM
|
Bayesian Influence Methods with Missing Covariates in Survival Analysis
Diana Lam, The University of North Carolina at Chapel Hill; Joseph G. Ibrahim, The University of North Carolina at Chapel Hill; Hongtu Zhu, The University of North Carolina at Chapel Hill
5:05 PM
|
Time-Dependent Cross-Ratio Estimation
Bin Nan, University of Michigan; Tianle Hu, University of Michigan; Xihong Lin, Harvard School of Public Health; James Robins, Harvard School of Public Health
5:20 PM
|
|
Monday, 08/02/2010
|
Measuring the Rectangularization of Survival Functions Using the Gompertz Distribution
Peter Oskar Pflaumer, Technical University of Dortmund
|
Analysis of Overall Survival When Length of Treatment and Treatment Switching Are Time-Dependent Outcomes of Oncology Trials
Jinwei Yuan, ICON Clinical Research
|
Survival Methods for Modeling the Time to Drop-Out in Pain Studies
Tilda Chuang, Abbott Laboratories; Wei Liu, Abbott Laboratories ; Sandeep Dutta, Abbott Laboratories
|
Competing Risks Methods in Safety Analysis of Oncology Clinical Trials
Sofia Paul, Novartis Pharmaceuticals Corporation; Bingqing Zhou, The University of North Carolina at Chapel Hill; Samit Hirawat, Novartis Pharma; Glen Laird, Novartis Pharmaceuticals Corporation
|
Joint Analysis of Survival Time and Longitudinal Categorical Outcomes
Jaeun Choi, The University of North Carolina at Chapel Hill; Jianwen Cai, The University of North Carolina at Chapel Hill; Donglin Zeng, The University of North Carolina at Chapel Hill
8:55 AM
|
Detecting Gene-Gene Interactions with Survival Times Based on Generalized Multifactor Dimensionality Reduction Method
Seungyeoun Lee, Sejong University; Min-Seok Kwon, Seoul National University; Jaebong Lee, Sejong University; Taesung Park, Seoul National University
9:20 AM
|
Contact Histories from the Survey of Grouped Individuals: Multivariate Multilevel Survival Analysis of Grouped Censored Data with Competing Risks
Hiroaki Minato, NORC
9:50 AM
|
A Multistate Modeling and Prediction of Survival Distribution Using Information on Subject's Tumor Response Over Time
Shengyan Hong, MedImmune; Iiya Lipkovich, Eli Lilly and Company; Yan Daniel Zhao, Eli Lilly and Company
9:50 AM
|
Relaxed Estimating Equations for Sparse Mark Variable Regression
Brent Johnson, Emory University
10:35 AM
|
Landmark Prediction of Survival
Layla Parast, Harvard University; Tianxi Cai, Harvard School of Public Health
10:35 AM
|
Multilevel Bayesian models of survival and zero-inflated longitudinal patient-reported outcomes
Laura A. Hatfield, University of Minnesota; Mark E. Boye, Eli Lilly and Company; Michelle Denise Hackshaw, Eli Lilly and Company; Bradley P. Carlin, University of Minnesota
10:55 AM
|
Comparing the Cumulative False-Positive Risk of Screening Mammography Programs Using a Discrete Time Survival Model Allowing for Nonignorable Drop-Out
Rebecca Hubbard, Group Health Research Institute; Diana Miglioretti, Group Health Research Institute
11:05 AM
|
A Bayesian Model for Misclassified Binary Outcomes and Correlated Survival Data, with Applications to Breast Cancer
Min Yi, The University of Texas Health Science Center at Houston; Sheng Luo, The University of Texas School of Public Health; Xuelin Huang, MD Anderson Cancer Center; Kelly K. Hunt, MD Anderson Cancer Center
11:15 AM
|
Semiparametric Regression Inference for Tumor Progression in Cancer Studies
Chen Hu, University of Michigan; Alexander Tsodikov, University of Michigan
11:20 AM
|
Survival Analysis with Error-Prone Time-Varying Covariates: A Risk Set Calibration Approach
Xiaomei Liao, Harvard University; David M. Zucker, Hebrew University; Yi Li, Harvard University/Dana-Farber Cancer Institute; Donna Spiegelman, Harvard University
11:50 AM
|
Improved Survival Modeling Using a Reduced Piecewise Exponential Approach
Gang Han, Moffitt Cancer Center & Research Institute; Michael J. Schell, Moffitt Cancer Center; Jongphil Kim, Moffitt Cancer Center & Research Institute
12:05 PM
|
Predicting Renal Graft Failure Using Multivariate Longitudinal Profiles
Geert Verbeke, I-Biostat; Steffen Fieuws, I-BioStat
2:05 PM
|
Confidence Intervals for Median Cost Estimation with Censored Data
Hongwei Zhao, Texas A&M Health Science Center; Chen Zuo, Renmin University of China; Heejung Bang, Weill Cornell Medical College
2:25 PM
|
A Joint Longitudinal and Illness-Death Model
Elizabeth Renata Brown, University of Washington
2:25 PM
|
Hypothesis Testing of Treatment Policies in Two-Stage Randomization Designs
Xiang Guo, sanofi-aventis (China); Anastasios Tsiatis, North Carolina State University
2:30 PM
|
Fitting High-Dimensional Joint Models for Longitudinal and Time-to-Event Data Using Laplace Approximations
Dimitris Rizopoulos, Erasmus University Medical Center
2:45 PM
|
Design and Analysis of Discrete-Time Survival Studies with Pooled Biomarker Assessment
Paramita Saha, National Institute of Environmental Health Sciences; Clarice R. Weinberg, National Institute of Environmental Health Sciences
2:45 PM
|
Causal Inference for the Comparison of Dynamic Treatment Regimens
Cecilia Cotton, University of Waterloo; Patrick Heagerty, University of Washington
2:55 PM
|
Estimating Lifetime or Episode-of-Illness Costs Under Censoring
Anirban Basu, The University of Chicago; Willard G. Manning, The University of Chicago
3:05 PM
|
A Joint Model for the Analysis of Multiscale Time to Events and Longitudinal Binary Data
Rajeshwari Sundaram, Eunice Kennedy Shriver National Institute of Child Health and Human Development; Alexander Mclain, Eunice Kennedy Shriver National Institute of Child Health and Human Development; Paul S. Albert, Eunice Kennedy Shriver National Institute of Child Health and Human Development; Germaine M. Buck Louis, Eunice Kennedy Shriver National Institute of Child Health and Human Development; Kirsten J. Lum, The Johns Hopkins University
3:05 PM
|
Bayesian Joint Model of Multivariate Ordinal Data with Competing Risks Survival Time
Pulak Ghosh, Indian Institute of Management, Bangalore
3:05 PM
|
Grouped Time-Transformation Model with Sterile Fraction: An Application to Time to Pregnancy
Alexander McLain, National Institutes of Health; Rajeshwari Sundaram, Eunice Kennedy Shriver National Institute of Child Health and Human Development
3:25 PM
|
|
Tuesday, 08/03/2010
|
A New Method for the Comparison of Survival Distributions
Xun Lin, Pfizer Global Research and Development; Qiang Xu, FDA
|
Data-Driven Confidence Interval for the Difference of Two Median Survival Times
Yu-Mei Chang, Tunghai University
|
A Consistent Estimator of the Absolute Deviation Between Predicted and Observed Survival Functions
Matthias Schmid, University of Erlangen-Nuremberg
|
Comparing Mammography Visits in High and Low Repeat Rate Facilities
Jonathan D. Mahnken, The University of Kansas Medical Center; Jianghua (Wendy) He, The University of Kansas Medical Center; Hung-Wen Yeh, The University of Kansas Medical Center; Niaman Nazir, The University of Kansas Medical Center; Linda L. Jianas, The University of Kansas Medical Center; Kimberly K. Engelman, The University of Kansas Medical Center
|
On the Repeated Estimation of Survival Time Quantiles for a Time-to-Event Study in Follow-Up Stage
Sunhee Kwon Ro, Onyx Pharmaceuticals; Yu-Lin Chang, Onyx Pharmaceuticals
|
A Comparison of Change Point Methods for Lymph Node Risk Factors in Three Cancers
Marianne Huebner, Mayo Clinic; Rui Qin, Mayo Clinic
|
Proportional Hazards Regression for the Analysis of Failure Time Data with Outcome-Dependent Sampling and Dependent Censoring
Hui Zhang, University of Michigan; John David Kalbfleisch, University of Michigan; Douglas E. Schaubel, University of Michigan
|
Joint Analysis of Symptom and Progression-Free Survival Endpoints in Previously Treated Malignant Pleural Mesothelioma
Michelle D. Hackshaw, Walden University; Mark E. Boye, Eli Lilly and Company; Teena M. West, Eli Lilly and Company; Angela W. Prehn, Walden University; Wei Shen, Eli Lilly and Company; Luping Zhao, Eli Lilly and Company
8:35 AM
|
Estimating Colorectal Cancer Screening in the Presence of Missing Data in a Population with a Resistant Subset and Multiple Observations
Yolanda Cecile Hagar, University of California, Davis; Laurel Beckett, University of California, Davis; Danielle Harvey, University of California, Davis School of Medicine; Joshua Fenton, University of California, Davis School of Medicine
9:05 AM
|
A Re-examination of the Analysis of Prevalent Cohort Survival Data
Marco Carone, Johns Hopkins Bloomberg School of Public Health; Masoud Asgharian, McGill University; Daniel O. Scharfstein, Johns Hopkins Bloomberg School of Public Health
9:35 AM
|
Nonparametric MLE for Doubly Censored Data with Frailty
Yu-Ru Su, University of California, Davis; Jane-Ling Wang, University of California, Davis
9:55 AM
|
Survival Analysis Without Survival Data: Estimation by Comparing Explanatory Variables from Unbiased and Length-Biased Samples
Kwun Chuen Gary Chan, University of Washington
9:55 AM
|
A Nested Accelerated Failure Time Model for Times to Disease Recurrence and Survival
Xuelin Huang, MD Anderson Cancer Center; Jing Ning, The University of Texas Health Science Center at Houston
10:35 AM
|
Random Delayed Effects and the Power of the Unweighted Log-Rank Test in Survival Trials
Jonathan Siegel, Bristol-Myers Squibb
10:35 AM
|
Change-Point Analysis of Survival Data with Application in Clinical Trials
Xuan Chen, sanofi pasteur; Michael Baron, The University of Texas at Dallas
11:05 AM
|
A Multvariate Frailty Model for Disease Recurrences and Survival
Sijin Wen, MD Anderson Cancer Center; Xuelin Huang, MD Anderson Cancer Center; Ralph F. Frankowski, The University of Texas School of Public Health
11:35 AM
|
Multiple Imputation Method for Disclosure Limitation in Longitudinal Data
Di An, Merck & Co., Inc.; Roderick Joseph Little, University of Michigan; James W. McNally, University of Michigan
11:35 AM
|
An Alternative to the Peto Analysis for Two-Year Carcinogenicity Studies and to Tarone's Test for Trend on Censored Survival Data
Arthur Roth, Private consultant
11:35 AM
|
Estimating Progression-Free Survival When the Progression Status of Some Patients Is Unknown
Ying Yuan, MD Anderson Cancer Center; Peter F. Thall, MD Anderson Cancer Center; Johannes Wolff, MD Anderson Cancer Center
11:55 AM
|
A Novel Rank Rest for a Time-to-Event Outcome That Incorporates Information on a Surrogate Event
Pamela A. Shaw, National Institute of Allergy and Infectious Diseases; Michael P. Fay, National Institute of Allergy and Infectious Diseases
2:05 PM
|
Genes Selection and Components Retention for Supervised Survival Prediction Models
Keyue Ding, Queen's University
2:05 PM
|
Shrinkage Nonparametric Estimation of Median Survival Time from Censored Data
Mohammad Hossein Rahbar, The University of Texas Health Science Center at Houston; Weiwei Wang, The University of Texas Health Science Center at Houston; Jing Ning, The University of Texas Health Science Center at Houston
2:05 PM
|
Sample-Size Calculation for the Andersen-Gill Model in the Presence of Subject Heterogeneity in the Baseline Risk
Antje Jahn-Eimermacher, University of Mainz; Katharina Ingel, University of Mainz
2:20 PM
|
Modeling H1N1 Vaccination Rates
Nadarajasundaram Ganesh, NORC; James A. Singleton, National Center for Immunization and Respiratory Diseases; Kennon R. Copeland, NORC; Tammy Santibanez, National Center for Immunization and Respiratory Diseases; Nicholas Davis, NORC
2:20 PM
|
Incorporating Sampling Bias in Analyzing Bivariate Survival Data with Interval Sampling and Application to HIV Research
Hong Zhu, Johns Hopkins Bloomberg School of Public Health; Mei-Cheng Wang, The Johns Hopkins University
2:25 PM
|
Bayesian Median Regression for Censored Survival Data via Transform-Both-Sides Model
Debajyoti Sinha, Florida State University; Jian-Chang Lin, Florida State University; Stuart R. Lipsitz, Brigham and Women's Hospital
2:25 PM
|
Two-Sample Semiparametric Proportional (Reverse) Hazard Model
Zhong Guan, Indiana University South Bend; Cheng Peng, University of Southern Maine
2:35 PM
|
Principal Stratification Methods for Evaluating Immunological Surrogate Endpoints in a Vaccine Efficacy Trial
Peter Gilbert, Fred Hutchinson Cancer Research Center
2:45 PM
|
Nonparametric Mixture Regression for Survival Data
Matthew Taddy, Chicago Booth
2:45 PM
|
Checking the Short-Term and Long-Term Hazard Ratio Model for Survival Data
Song Yang, National Heart, Lung, and Blood Institute; Yichuan Zhao, Georgia State University
2:50 PM
|
Inference for Treatment Efficacy on Survival Probability in Randomized Clinical Trials with Noncompliance
Ying Zhou, University of California, Los Angeles
3:05 PM
|
|
Wednesday, 08/04/2010
|
Calculation of Sample Size for Testing the Performance of Disease Risk Prediction Models from Survival Analysis Based on Harrell's C Discrimination Index
Ching-Yu Huang, National Health Research Institutes, Taiwan; Hsing-Yi Chang, National Health Research Institutes, Taiwan; Wen-ling Liu, National Health Research Institutes, Taiwan
|
Risk Stratification Using Survival and Microarray Gene Expression Data
Pingping Qu, Cancer Research and Biostatistics (CRAB); John D. Shaughnessy Jr., University of Arkansas for Medical Sciences; Michael LeBlanc, Fred Hutchinson Cancer Research Center; Jeff Haessler, Cancer Research and Biostatistics (CRAB); Bart Barlogie, University of Arkansas for Medical Sciences; John Crowley, Cancer Research and Biostatistics (CRAB)
|
The Impact of Functional Impairment on the Survival of Patients with Alzheimer's Disease
Fuwen Liang, MD Anderson Cancer Center
|
Variable Selection in Censored Quantile Regression
Huixia Wang, North Carolina State University; Jianhui Zhou, University of Virginia
8:35 AM
|
Assessing Agreement for Frailty Models
Amita K. Manatunga, Emory University ; Ying Guo, Emory University
8:35 AM
|
Application of Left Truncation Survival Methods in a Large Disease Registry: A Case Study with Practical Implications
Dave P. Miller, ICON Clinical Research; Aimee J. Foreman, ICON Clinical Research
8:35 AM
|
Semiparametric Bayesian Modeling of Spatio-Survival Data Under Cure Fraction
Sandra Milena Hurtado Rua, University of Connecticut; Dipak K. Dey, University of Connecticut
8:50 AM
|
Sparse Semisupervised Methods for Predicting Patient Survival Probabilities with Large-Scale Biological Data
Karthik Devarajan, Fox Chase Cancer Center
8:50 AM
|
Testing Small Center Events in Multicenter Trials Using Survival Modeling
Usha Sita Govindarajulu, Brigham and Women's Hospital, Harvard Medical School; Elizabeth J. Malloy, American University; James Dziura, Yale University
9:05 AM
|
Matching Methods for Estimating the Effect on Survival of a Time-Dependent Treatment
Douglas E. Schaubel, University of Michigan; Yun Li, University of Michigan
9:15 AM
|
Bayesian Adaptive Phase II/III Clinical Trial Design Using the Relationship Between Tumor Response and Survival
Donald Arthur Berry, MD Anderson Cancer Center; Haiying Pang, MD Anderson Cancer Center
9:20 AM
|
PartDSA: The Partitioning Deletion/Substitution/Addition Algorithm for Creating Survival Risk Groups
Karen Lostritto, Yale University; Rob Strawderman, Cornell University; Annette Molinaro, Yale University
9:20 AM
|
Distribution-Free Inference for Arbitrary Functionals of Survival
Kyle D. Rudser, University of Minnesota; Michael LeBlanc, Fred Hutchinson Cancer Research Center; Scott Emerson, University of Washington
9:35 AM
|
A Joint Model of Recurrent Events and a Terminal Event with a Nonparametric Covariate Function
Zhangsheng Yu, Indiana University School of Medicine; Lei Liu, University of Virginia
9:35 AM
|
Random Effect Bivariate Survival Models and Stochastic Comparisons
Ramesh C. Gupta, University of Maine; Rameshwar D. Gupta, University of New Brunswick
9:35 AM
|
Cluster Detection Using Scan Statistics and Risk Factors for Encephalitis from West Nile Virus Infection
Sarah Baraniuk, The University of Texas Health Science Center at Houston; Kristy Murray, The University of Texas Health Science Center at Houston
9:35 AM
|
Adaptive Nonparametric Variable Selection for Survival Data
Lisha Chen, Yale University
10:35 AM
|
Flexible Modification of Survival Trials
Cyrus R. Mehta, Cytel Inc.; Mikhail P. Salganik, Cytel Inc.
11:15 AM
|
Covariate-Adjusted Response-Adaptive Randomization Design with Survival Responses
Hongjian Zhu, University of Virginia; Feifang Hu, University of Virginia
11:15 AM
|
Sequential Design of Phase II--III Cancer Trials
Tze Leung Lai, Stanford University; Philip Lavori, Stanford University; Mei-Chiung Shih, Stanford University
2:05 PM
|
Performance Measures for Survival Prediction Models: An Overview
Linda M. Peelen, Julius Center for Health Sciences and Primary Care UMC Utrecht; Nina P. Paynter, Brigham and Women's Hospital; Karel G.M. Moons, Julius Center for Health Sciences and Primary Care UMC Utrecht; Nancy Cook, Brigham and Women's Hospital
2:05 PM
|
The Role of the Statistician in the Appraisal of Health Technologies by the UK National Institute for Clinical Excellence (NICE)
Michael Joseph Campbell, University of Sheffield
2:05 PM
|
Bagged Estimators for Joint Longitudinal and Survival Analysis
Harsh Singhal, Bank of America
2:20 PM
|
Performance of Prediction Measures in a Survival Setting
Nina P. Paynter, Brigham and Women's Hospital; Linda M. Peelen, Julius Center for Health Sciences and Primary Care UMC Utrecht; Nancy Cook, Brigham and Women's Hospital
2:25 PM
|
Bayesian Clustering for Failure-Time Data
Gary Rosner, The Johns Hopkins University; Peter Mueller, MD Anderson Cancer Center; Fernando Quintana, Pontificia Universidad Católica de Chile
2:25 PM
|
Variable Selection for Identifying Environmental Contaminants Associated with Human Fecundity
Sung Duk Kim, Eunice Kennedy Shriver National Institute of Child Health and Human Development; Rajeshwari Sundaram, Eunice Kennedy Shriver National Institute of Child Health and Human Development; Germaine M. Buck Louis, Eunice Kennedy Shriver National Institute of Child Health and Human Development
2:35 PM
|
On the Asymptotic Behaviour of Random Cumulative Hazards
Pierpaolo De Blasi, University of Turin/Collegio Carlo Alberto; Giovanni Peccati, University of Luxembourg; Igor Pruenster, University of Turin
2:45 PM
|
Bayesian Variable Selection in Cox Proportional Hazard Models for Survival Data
Kyu Ha Lee, University of Missouri-Columbia; Sounak Chakraborty, University of Missouri-Columbia; Jianguo Sun, University of Missouri
2:50 PM
|
Bias Correction in the Hierarchical Likelihood Approach to the Analysis of Multivariate Survival Data
Jihyoun Jeon, Fred Hutchinson Cancer Research Center; Li Hsu, Fred Hutchinson Cancer Research Center; Malka Gorfine, Technion - Israel Institute of Technology
2:50 PM
|
Comparing Non-Nested Survival Prediction Models
Ulla Brasch Mogensen, University of Copenhagen; Thomas A. Gerds, University of Copenhagen
3:05 PM
|
CUSUMs for Survival Outcomes with Dependent Censoring: Application to Monitoring Waitlist Mortality in Liver Transplant Programs
Jie (Rena) Sun, University of Michigan; John David Kalbfleisch, University of Michigan; Douglas E. Schaubel, University of Michigan
3:05 PM
|
Statistical Methods for a Phase II Oncology Trial with a GMI Endpoint
Stephanie Ann Kovalchik, University of California, Los Angeles; William Leonard Mietlowski, Novartis Oncology
3:20 PM
|
Effect of Age at Transfer on Survival Among Preterm Newborns
Kenneth Pietz, Baylor College of Medicine; Jochen Profit, Texas Children's Hospital; Gould Jeffrey, Stanford University Medical Center
3:20 PM
|
Predicting Patient Survival from Proteomic Profile Using MALDI-TOF Mass Spectrometry Data
Farida Mostajabi, University of Louisville; Susmita Datta, University of Louisville
3:35 PM
|
|
Thursday, 08/05/2010
|
Mixture Cure Model with Random Effects for Interval-Censored Survival Data
Liming Xiang, Nanyang Technological University; Xiangmei Ma, Nanyang Technological University
8:50 AM
|
A Natural Nonparametric Generalization of Parametric Statistical Models
Timothy Edward Hanson, University of Minnesota
9:00 AM
|
Quantile Regression Methods for Doubly Censored Data from Registry Studies
Shuang Ji, Emory University; Limin Peng, Emory University; Yu Cheng, University of Pittsburgh; Huichuan Lai, University of Wisconsin
9:05 AM
|
Adaptive Sample Size Re-Estimation in Oncology Trials
Pralay Mukhopadhyay, Bristol-Myers Squibb
9:20 AM
|
Modeling Trajectories of Delirium Using Mixture Models
Long Huu Ngo, Beth Israel Deaconess Medical Center/Harvard Medical School; Edward R. Marcantonio, Beth Israel Deaconess Medical Center/Harvard Medical School
9:20 AM
|
Asymptotic Theory for Q-Learning with Support Vector Regression Under Right Censoring
Yair Goldberg, The University of North Carolina at Chapel Hill; Michael Kosorok, The University of North Carolina at Chapel Hill; Donglin Zeng, The University of North Carolina at Chapel Hill; Yufan Zhao, Amgen Inc.
9:25 AM
|
Application of the Pattern Mixture Model to Mini Mental Status Exam (MMSE) Scores in a Radiation Therapy Oncology Group (RTOG) Trial for Brain Tumors
Kyounghwa Bae, Radiation Therapy Oncology Group; Seunghee Baek, University of Pennsylvania; James Dignam, Radiation Therapy Oncology Group
9:50 AM
|
Mixed-Effects Cox Models for Gene Set Analysis
Terry Therneau, Mayo Clinic; Marianne Huebner, Mayo Clinic
10:35 AM
|
Blending Vital Statistics Inputs for Life-Table Analysis of Nursing Home Duration
Gary Simon, New York University
10:35 AM
|
Using Integrated Difference Between Two Kaplan-Meier Curves for Quantifying Treatment Contrast in Comparative Clinical Trials with Event Time Observations
Lihui Zhao, Harvard School of Public Health
10:35 AM
|
A Bayesian Joint Survival Model for Predicting Treatment Efficacy via Quantitative MRI
Jincao Wu, University of Michigan; Timothy D. Johnson, University of Michigan
11:35 AM
|
Unified Modeling Methods for Curve Predictors and Different Responses
Xiaohui Wang, The University of Texas-Pan American; Veera Baladandayuthapani, MD Anderson Cancer Center; Bani K. Mallick, Texas A&M University; Kim-Ahn Do, MD Anderson Cancer Center; Shubhankar Ray, Merck & Co., Inc.
11:50 AM
|
|